Abstract
The development of the membrane oxygenator for the use in open heart surgery in the late 1960s was a major advance in cardiopulmonary bypass technology. Compared with the previous generation of bubble oxygenators, these devices were much less destructive of blood components and extended the safe period for cardiopulmonary bypass. It was a matter of time therefore before this technology migrated from the operating room to the ICU to support patients dying of hypoxemia who could not be ventilated. In 1970, Baffes used extracorporeal support in children with congenital heart disease after open heart surgery (Baffes et al. 1970). The first successful use of a membrane oxygenator to support a patient with acute hypoxic respiratory failure (AHRF) was published in 1972 using the Bramson lung (Hill et al. 1972). Following the publication of further case series (Gille and Bagniewski 1976), an NIH-sponsored randomized trial was set up in 1975 to compare the use of veno-venous (V-V) ECMO in ARDS with what was then standard-of-care positive-pressure ventilation (Zapol et al. 1979). The entry criteria were modest by today’s standards (FiO2 0.6, PEEP ≥6 cmH2O for 2 h or more). Ninety patients were randomized, but the disappointing survival of 10 % in both arms of this study led to ECMO being largely abandoned as a treatment for AHRF in adults in North America. Bartlett, who was a lead investigator in the trial, then pioneered the use of ECMO in neonatal respiratory failure and published the first case series of 45 patients from the University of Michigan in 1982 with a 50 % survival (Bartlett et al. 1982). He set up the Extracorporeal Life Support Organization (ELSO), and the Registry now contains a database of over 30,000 patients where ECMO has been used for either pulmonary or cardiac support. Over 25,000 neonates with AHRF have been treated with an overall survival of 80 %. Beginning in the late 1980s, an increasing number of pediatric patients outside the newborn period with respiratory failure unresponsive to conventional treatments have had ECMO used as a rescue therapy. Reports from the Registry show data on over 3,000 patients with an overall survival of 60 % (ELSO Registry 2010).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baffes TG, Fridman JL, Bicoff JP, Whitehill JL (1970) Extracorporeal circulation for support of palliative cardiac surgery in infants. Ann Thorac Surg 10(4):354–363
Bartlett RH, Andrews AF, Toomasian JM, Haiduc NJ, Gazzaniga AB (1982) Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery 92(2):425–433
Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB (1985) Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76(4):479–487
Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P (2011) Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 12(3):277–281
Brown KL, Walker G, Grant DJ, Tanner K, Ridout DA, Shekerdemian LS et al (2004) Predicting outcome in ex-premature infants supported with extracorporeal membrane oxygenation for acute hypoxic respiratory failure. Arch Dis Child Fetal Neonatal Ed 89(5):F423–F427
Clement KC, Fiser RT, Fiser WP, Chipman CW, Taylor BJ, Heulitt MJ et al (2010) Single-institution experience with interhospital extracorporeal membrane oxygenation transport: a descriptive study. Pediatr Crit Care Med 11(4):509–513
Conrad SA, Green R, Scott LK (2007) Near-fatal pediatric asthma managed with pumpless arteriovenous carbon dioxide removal. Crit Care Med 35(11):2624–2629
Coppola CP, Tyree M, Larry K, DiGeronimo R (2008) A 22-year experience in global transport extracorporeal membrane oxygenation. J Pediatr Surg 43(1):46–52
Dominguez TE, Brown KL (2010) Activated recombinant factor VII and extracorporeal membrane oxygenation: everything is all right, nothing is wrong? Pediatr Crit Care Med 11(1):155–156
Dominguez TE, Mitchell M, Friess SH, Huh JW, Manno CS, Ravishankar C et al (2005) Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation. Pediatr Crit Care Med 6(3):348–351
ELSO Registry (2010) Extracorporeal Life Support Organization http://www.elsonet.org
Fackler JC, Bohn D, Green TP, Heulitt M, Hirshl R, Klein M et al (1997) ECMO for ARDS; stopping a RCT. Am J Respir Crit Care Med 155: A504 (abstract)
Fischer S, Hoeper MM, Tomaszek S, Simon A, Gottlieb J, Welte T et al (2007) Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: the initial Hannover experience. ASAIO J 53(2):168–170
Fliman PJ, deRegnier RA, Kinsella JP, Reynolds M, Rankin LL, Steinhorn RH (2006) Neonatal extracorporeal life support: impact of new therapies on survival. J Pediatr 148(5):595–599
Florchinger B, Philipp A, Klose A, Hilker M, Kobuch R, Rupprecht L et al (2008) Pumpless extracorporeal lung assist: a 10-year institutional experience. Ann Thorac Surg 86(2):410–417; discussion 417
Flori HR, Glidden DV, Rutherford GW, Matthay MA (2005) Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 171(9):995–1001
Fortenberry JD, Meier AH, Pettignano R, Heard M, Chambliss CR, Wulkan M (2003) Extracorporeal life support for posttraumatic acute respiratory distress syndrome at a children’s medical center. J Pediatr Surg 38(8):1221–1226
Gattinoni L, Pesenti A, Mascheroni D, Marcolin R, Fumagalli R, Rossi F et al (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256(7):881–886
Gille JP, Bagniewski AM (1976) Ten years of use of extracorporeal membrane oxygenation (ECMO) in the treatment of acute respiratory insufficiency (ARI). Trans Am Soc Artif Intern Organs 22:102–109
Goretsky MJ, Greenhalgh DG, Warden GD, Ryckman FC, Warner BW (1995) The use of extracorporeal life support in pediatric burn patients with respiratory failure. J Pediatr Surg 30(4):620–623
Gow KW, Wulkan ML, Heiss KF, Haight AE, Heard ML, Rycus P et al (2006) Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experience. J Pediatr Surg 41(4):662–667
Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF (1996) The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med 24(2):323–329
Gupta M, Shanley TP, Moler FW (2008) Extracorporeal life support for severe respiratory failure in children with immune compromised conditions. Pediatr Crit Care Med 9(4):380–385
Haefner SM, Bratton SL, Annich GM, Bartlett RH, Custer JR (2003) Complications of intermittent prone positioning in pediatric patients receiving extracorporeal membrane oxygenation for respiratory failure. Chest 123(5):1589–1594
Halasa NB, Barr FE, Johnson JE, Edwards KM (2003) Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 112(6 Pt 1):1274–1278
Hebbar KB, Petrillo-Albarano T, Coto-Puckett W, Heard M, Rycus PT, Fortenberry JD (2009) Experience with use of extracorporeal life support for severe refractory status asthmaticus in children. Crit Care 13(2):R29
Hill JD, O’Brien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ et al (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 286(12):629–634
Horwitz JR, Cofer BR, Warner BW, Cheu HW, Lally KP (1998) A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatr Surg 33(11):1610–1613
Kane TD, Greenhalgh DG, Warden GD, Goretsky MJ, Ryckman FC, Warner BW (1999) Pediatric burn patients with respiratory failure: predictors of outcome with the use of extracorporeal life support. J Burn Care Rehabil 20(2):145–150
Khoshbin E, Roberts N, Harvey C, Machin D, Killer H, Peek GJ et al (2005) Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation. ASAIO J 51(3):281–287
Kolovos NS, Schuerer DJ, Moler FW, Bratton SL, Swaniker F, Bartlett RH et al (2002) Extracorporeal life support for pulmonary hemorrhage in children: a case series. Crit Care Med 30(3):577–580
Leesin MS, El-Eid SE, Klein MD, Cullen ML (1996) Extracorporeal membrane oxygenation in pediatric respiratory failure secondary to smoke inhalation injury. J Pediatr Surg 31:185–1287
Linden V, Karlen J, Olsson M, Palmer K, Ehren H, Henter JI et al (1999) Successful extracorporeal membrane oxygenation in four children with malignant disease and severe Pneumocystis carinii pneumonia. Med Pediatr Oncol 32(1):25–31
Meister B, Zelger B, Kropshofer G, Klein-Franke A, Crazzolara R, Fruhwirth M et al (2010) Extracorporeal membrane oxygenation as a rescue therapy for leukaemic children with pulmonary failure. Br J Haematol 148(1):126–131
Moler FW, Palmisano JM, Green TP, Custer JR (1993) Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation. J Pediatr 123(1):46–52
Niebler RA, Punzalan RC, Marchan M, Lankiewicz MW (2010) Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation. Pediatr Crit Care Med 11(1):98–102
O’Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB et al (1989) Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 84(6):957–963
Pettignano R, Heard M, Davis R, Labuz M, Hart M (1998) Total enteral nutrition versus total parenteral nutrition during pediatric extracorporeal membrane oxygenation. Crit Care Med 26(2):358–363
Pettignano R, Fortenberry JD, Heard ML, Labuz MD, Kesser KC, Tanner AJ et al (2003) Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure. Pediatr Crit Care Med 4(3):291–298
Pierre EJ, Zwischenberger JB, Angel C, Upp J, Cortiella J, Sankar A et al (1998) Extracorporeal membrane oxygenation in the treatment of respiratory failure in pediatric patients with burns. J Burn Care Rehabil 19(2):131–134
Pooboni S, Roberts N, Westrope C, Jenkins DR, Killer H, Pandya HC et al (2003) Extracorporeal life support in pertussis. Pediatr Pulmonol 36(4):310–315
Prodhan P, Fiser RT, Cenac S, Bhutta AT, Fontenot E, Moss M et al (2010) Intrahospital transport of children on extracorporeal membrane oxygenation: indications, process, interventions, and effectiveness. Pediatr Crit Care Med 11(2):227–233
Ricci D, Boffini M, Del Sorbo L, El Qarra S, Comoglio C, Ribezzo M et al (2010) The use of CO2 removal devices in patients awaiting lung transplantation: an initial experience. Transplant Proc 42(4):1255–1258
Romano MJ (2007) Near-fatal pediatric asthma managed with pumpless arteriovenous carbon dioxide removal: help at the margin. Crit Care Med 35(11):2663–2664
Roy BJ, Rycus P, Conrad SA, Clark RH (2000) The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. Pediatrics 106(6):1334–1338
Siden HB, Sanders GM, Moler FW (1994) A report of four cases of acute, severe pulmonary hemorrhage in infancy and support with extracorporeal membrane oxygenation. Pediatr Pulmonol 18(5):337–341
Strueber M, Hoeper MM, Fischer S, Cypel M, Warnecke G, Gottlieb J et al (2009) Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant 9(4):853–857
Swaniker F, Kolla S, Moler F, Custer J, Grams R, Barlett R et al (2000) Extracorporeal life support outcome for 128 pediatric patients with respiratory failure. J Pediatr Surg 35(2):197–202
Trachsel D, McCrindle BW, Nakagawa S, Bohn D (2005) Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med 172(2):206–211
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group (1996) Lancet 348(9020):75–82
Vats A, Pettignano R, Culler S, Wright J (1998) Cost of extracorporeal life support in pediatric patients with acute respiratory failure. Crit Care Med 26(9):1587–1592
Weber-Carstens S, Bercker S, Hommel M, Deja M, MacGuill M, Dreykluft C et al (2009) Hypercapnia in late-phase ALI/ARDS: providing spontaneous breathing using pumpless extracorporeal lung assist. Intensive Care Med 35(6):1100–1105
Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH et al (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196
Zimmermann M, Bein T, Arlt M, Philipp A, Rupprecht L, Mueller T et al (2009) Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care 13(1):R10
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bohn, D. (2015). Extracorporeal Membrane Oxygenation in Acute Hypoxic Respiratory Failure. In: Rimensberger, P. (eds) Pediatric and Neonatal Mechanical Ventilation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01219-8_66
Download citation
DOI: https://doi.org/10.1007/978-3-642-01219-8_66
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01218-1
Online ISBN: 978-3-642-01219-8
eBook Packages: MedicineMedicine (R0)